Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

381 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The epithelial barrier: The gateway to allergic, autoimmune, and metabolic diseases and chronic neuropsychiatric conditions.
Yazici D, Ogulur I, Pat Y, Babayev H, Barletta E, Ardicli S, Bel Imam M, Huang M, Koch J, Li M, Maurer D, Radzikowska U, Satitsuksanoa P, Schneider SR, Sun N, Traidl S, Wallimann A, Wawrocki S, Zhakparov D, Fehr D, Ziadlou R, Mitamura Y, Brüggen MC, van de Veen W, Sokolowska M, Baerenfaller K, Nadeau K, Akdis M, Akdis CA. Yazici D, et al. Among authors: mitamura y. Semin Immunol. 2023 Nov;70:101846. doi: 10.1016/j.smim.2023.101846. Epub 2023 Oct 4. Semin Immunol. 2023. PMID: 37801907 Free article. Review.
Recent advances in the epithelial barrier theory.
Pat Y, Yazici D, D'Avino P, Li M, Ardicli S, Ardicli O, Mitamura Y, Akdis M, Dhir R, Nadeau K, Agache I, Ogulur I, Akdis CA. Pat Y, et al. Among authors: mitamura y. Int Immunol. 2024 Apr 3;36(5):211-222. doi: 10.1093/intimm/dxae002. Int Immunol. 2024. PMID: 38227765 Free PMC article. Review.
Factors Affecting Visual Acuity After Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration: A Multicenter Study in Japan.
Kominami A, Tomita S, Kato A, Ono K, Takeuchi M, Imazeki M, Terasaki H, Yamamoto Y, Jujo T, Wakuta M, Matsubara H, Mitamura Y, Kondo M, Kimura K, Takagi H, Gomi F, Sakamoto T, Yasukawa T; Japan Clinical Retina Study (J-CREST) Group. Kominami A, et al. Among authors: mitamura y. J Clin Med. 2024 Oct 19;13(20):6244. doi: 10.3390/jcm13206244. J Clin Med. 2024. PMID: 39458195 Free PMC article.
ALTERATION OF TREATMENT CHOICES AND THE VISUAL PROGNOSIS FOR DIABETIC MACULAR EDEMA IN THE ERA OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR DRUGS: Analysis of the STREAT-DME 2 Study.
Shimura M, Hirano T, Tsuiki E, Takamura Y, Morizane Y, Akiyama K, Yamamoto K, Hikichi T, Koto T, Kinoshita T, Kusuhara S, Yoshida S, Sakamoto SI, Kimura K, Sugimoto M, Kida T, Mitamura Y, Takatsuna Y, Washio N, Osaka R, Ueda T, Minamoto A, Kogo J, Okamoto F, Enaida H, Sakanishi Y, Nagaoka T, Gomi F, Sasaki M, Terasaki H, Iwase T, Tatsumi T, Nishi K, Shinoda K, Ueda S, Ueda-Consolvo T, Nakashizuka H, Murata T, Kitano S, Sakamoto T; J-CREST STREAT-DME 2 Study Group. Shimura M, et al. Among authors: mitamura y. Retina. 2025 Feb 1;45(2):335-344. doi: 10.1097/IAE.0000000000004301. Retina. 2025. PMID: 39423137 Free PMC article.
The epithelial barrier theory and its associated diseases.
Sun N, Ogulur I, Mitamura Y, Yazici D, Pat Y, Bu X, Li M, Zhu X, Babayev H, Ardicli S, Ardicli O, D'Avino P, Kiykim A, Sokolowska M, van de Veen W, Weidmann L, Akdis D, Ozdemir BG, Brüggen MC, Biedermann L, Straumann A, Kreienbühl A, Guttman-Yassky E, Santos AF, Del Giacco S, Traidl-Hoffmann C, Jackson DJ, Wang DY, Lauerma A, Breiteneder H, Zhang L, O'Mahony L, Pfaar O, O'Hehir R, Eiwegger T, Fokkens WJ, Cabanillas B, Ozdemir C, Kistler W, Bayik M, Nadeau KC, Torres MJ, Akdis M, Jutel M, Agache I, Akdis CA. Sun N, et al. Among authors: mitamura y. Allergy. 2024 Dec;79(12):3192-3237. doi: 10.1111/all.16318. Epub 2024 Oct 7. Allergy. 2024. PMID: 39370939 Free PMC article. Review.
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in diabetic macular edema: 2-year results from the Japan subgroup of the phase 3 YOSEMITE trial.
Shimura M, Oh H, Ueda T, Kitano S, Mitamura Y, Sato J, Iwasaki K, Hirakata A; YOSEMITE and RHINE Investigators. Shimura M, et al. Among authors: mitamura y. Jpn J Ophthalmol. 2024 Sep;68(5):511-522. doi: 10.1007/s10384-024-01078-y. Epub 2024 Jul 31. Jpn J Ophthalmol. 2024. PMID: 39083147 Free PMC article. Clinical Trial.
381 results